SUSQUEHANNA INTERNATIONAL GROUP, LLP - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 43 filers reported holding VYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,473
-58.8%
16,484
-33.9%
0.00%
Q3 2022$6,000
-14.3%
24,928
+143.7%
0.00%
Q1 2022$7,000
-92.4%
10,229
-88.7%
0.00%
Q4 2021$92,000
+360.0%
90,660
+534.1%
0.00%
Q3 2021$20,000
-94.0%
14,297
-85.1%
0.00%
Q2 2021$336,000
-29.1%
95,783
+38.2%
0.00%
Q1 2021$474,00069,3000.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders